Brief: Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results
09/11/2022 22:27
Nov 9 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS ANNOUNCES FISCAL 2023 FIRST QUARTER
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* KINTARA THERAPEUTICS INC- AT SEPTEMBER 30, 2022, KINTARA
HAD
CASH AND CASH EQUIVALENTS OF APPROXIMATELY $7.1 MILLION
* KINTARA THERAPEUTICS INC- FOR THREE MONTHS ENDED SEPTEMBER
30,
2022REPORTED A NET LOSS OF $0.07 PER SHARE
Source text for Eikon: ID:nPnbrnGJ5a
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.